One more from Targetedonc this time for AML. Everyone is talking about their own pathway but no one is talking about FTO, because they don’t have a drug in that space… opportunity!
https://www.targetedonc.com/view/expert-discusses-need-for-a-more-targeted-approach-in-acute-myeloid-leukemia
RACE: Marketing Blitz 2021-2022, page-105
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.85 |
Change
-0.015(0.80%) |
Mkt cap ! $315.0M | |||
| Open | High | Low | Value | Volume |
| $1.86 | $1.86 | $1.82 | $160.5K | 87.43K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 5658 | $1.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.86 | 1341 | 2 |
View Market Depth
| Last trade - 13.38pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.79 |
Change
-0.015 ( 4.85 %) |
||||
| Open | High | Low | Volume | ||
| $1.81 | $1.86 | $1.78 | 11936 | ||
| Last updated 14.08pm 14/06/2024 ? | |||||
| RAC (ASX) Chart |